- Home
- INTS vs MXE Comparison
INTS vs MXE Comparison
Compare INTS & MXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- MXE
- Stock Information
- Founded
- INTS 2012
- MXE 1990
- Country
- INTS United States
- MXE United States
- Employees
- INTS N/A
- MXE N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- MXE Finance Companies
- Sector
- INTS Health Care
- MXE Finance
- Exchange
- INTS Nasdaq
- MXE Nasdaq
- Market Cap
- INTS 33.4M
- MXE 36.6M
- IPO Year
- INTS 2023
- MXE N/A
- Fundamental
- Price
- INTS $2.23
- MXE $8.91
- Analyst Decision
- INTS Strong Buy
- MXE
- Analyst Count
- INTS 3
- MXE 0
- Target Price
- INTS $8.50
- MXE N/A
- AVG Volume (30 Days)
- INTS 26.6K
- MXE 5.8K
- Earning Date
- INTS 03-13-2025
- MXE 01-01-0001
- Dividend Yield
- INTS N/A
- MXE 2.66%
- EPS Growth
- INTS N/A
- MXE N/A
- EPS
- INTS N/A
- MXE N/A
- Revenue
- INTS N/A
- MXE N/A
- Revenue This Year
- INTS N/A
- MXE N/A
- Revenue Next Year
- INTS N/A
- MXE N/A
- P/E Ratio
- INTS N/A
- MXE N/A
- Revenue Growth
- INTS N/A
- MXE N/A
- 52 Week Low
- INTS $1.50
- MXE $8.40
- 52 Week High
- INTS $5.94
- MXE $11.51
- Technical
- Relative Strength Index (RSI)
- INTS 49.26
- MXE 62.09
- Support Level
- INTS $1.84
- MXE $8.73
- Resistance Level
- INTS $2.27
- MXE $9.08
- Average True Range (ATR)
- INTS 0.28
- MXE 0.18
- MACD
- INTS -0.01
- MXE 0.03
- Stochastic Oscillator
- INTS 56.36
- MXE 81.52
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.
About MXE Mexico Equity and Income Fund Inc. (The)
Mexico Equity and Income Fund Inc is a closed-end, non-diversified management investment company. It maintains an investment objective of long-term capital appreciation through investments in securities, primarily equity, listed on the Mexican Stock Exchange. The company provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.